ID
31372
Description
Study ID: 104507 Clinical Study ID: BEX104507 Study Title: Phase II Study of Iodine-131 Anti-B1 Antibody for Non Hodgkin’s Lymphoma Patients who have Previously Received Rituximab Patient Level Data: Study Listed on ClinicalStudyDataRequest.com Clinicaltrials.gov Identifier: NCT00996593 Sponsor: GlaxoSmithKline Collaborators: N/A Phase: Phase 2 Study Recruitment Status: Completed Generic Name: tositumomab Trade Name: Bexxar Study Indication: Lymphoma, Non-Hodgkin
Keywords
Versions (3)
- 7/23/18 7/23/18 -
- 8/18/18 8/18/18 -
- 3/15/21 3/15/21 - Dr. rer. medic Philipp Neuhaus
Copyright Holder
GlaxoSmithKline
Uploaded on
August 18, 2018
DOI
To request one please log in.
License
Creative Commons BY-NC 3.0
Model comments :
You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.
Itemgroup comments for :
Item comments for :
In order to download data models you must be logged in. Please log in or register for free.
Iodine-131 Anti-B1 Antibody for Non Hodgkin’s Lymphomas NCT00996593
Concomitant Medications and Transfusions and Adverse Experiences
- StudyEvent: ODM
Description
Concomitant Medications and Transfusions
Alias
- UMLS CUI-1
- C4284232
- UMLS CUI-2
- C0521115
- UMLS CUI-3
- C1879316
- UMLS CUI-4
- C0521115
Description
Drug or Blood Product
Data type
text
Alias
- UMLS CUI [1]
- C0013227
- UMLS CUI [2]
- C0456388
Description
Drug or Blood Product Dose
Data type
text
Alias
- UMLS CUI [1,1]
- C0013227
- UMLS CUI [1,2]
- C0178602
- UMLS CUI [2,1]
- C0456388
- UMLS CUI [2,2]
- C0178602
Description
Drug or Blood Product Dose Unit
Data type
text
Alias
- UMLS CUI [1,1]
- C0013227
- UMLS CUI [1,2]
- C0178602
- UMLS CUI [1,3]
- C0439148
- UMLS CUI [2,1]
- C0456388
- UMLS CUI [2,2]
- C0178602
- UMLS CUI [2,3]
- C0439148
Description
Route of drug administration
Data type
text
Alias
- UMLS CUI [1]
- C0013153
Description
Medication frequency | Transfusion (procedure); Frequencies (time pattern)
Data type
text
Alias
- UMLS CUI [1]
- C3476109
- UMLS CUI [2,1]
- C1879316
- UMLS CUI [2,2]
- C0439603
Description
Date treatment started
Data type
date
Alias
- UMLS CUI [1]
- C1531783
Description
Date treatment stopped
Data type
date
Alias
- UMLS CUI [1]
- C1531784
Description
continuing therapy
Data type
text
Alias
- UMLS CUI [1]
- C1553904
Description
Adverse Experiences
Alias
- UMLS CUI-1
- C0877248
Description
Adverse Experiences
Alias
- UMLS CUI-1
- C0877248
Description
adverse event; Numbers
Data type
integer
Alias
- UMLS CUI [1,1]
- C0877248
- UMLS CUI [1,2]
- C0237753
Description
Adverse event
Data type
text
Alias
- UMLS CUI [1]
- C0877248
Description
Adverse Event Grade Code
Data type
text
Alias
- UMLS CUI [1]
- C2985911
Description
Serious: Fatal or immediately life- threatening, permanently disabling, requires of prolongs hospitalization, or congenital anomaly.
Data type
boolean
Alias
- UMLS CUI [1]
- C1519255
Description
Adverse Event Onset Date
Data type
date
Alias
- UMLS CUI [1]
- C2985916
Description
Adverse event; End Date
Data type
date
Alias
- UMLS CUI [1,1]
- C0877248
- UMLS CUI [1,2]
- C0806020
Description
Adverse event; Continuous
Data type
text
Alias
- UMLS CUI [1,1]
- C0877248
- UMLS CUI [1,2]
- C0549178
Description
Adverse event; Frequencies (time pattern)
Data type
text
Alias
- UMLS CUI [1,1]
- C0877248
- UMLS CUI [1,2]
- C0439603
Description
Pharmaceutical Preparations; Therapeutic procedure; Measures
Data type
text
Alias
- UMLS CUI [1,1]
- C0013227
- UMLS CUI [1,2]
- C0087111
- UMLS CUI [1,3]
- C0079809
Description
Record all that apply
Data type
text
Alias
- UMLS CUI [1,1]
- C0087111
- UMLS CUI [1,2]
- C0079809
- UMLS CUI [1,3]
- C0205394
Description
Therapeutic procedure; Measures; Other; Specification
Data type
text
Alias
- UMLS CUI [1,1]
- C0087111
- UMLS CUI [1,2]
- C0079809
- UMLS CUI [1,3]
- C0205394
- UMLS CUI [1,4]
- C2348235
Description
Adverse Event Outcome
Data type
text
Alias
- UMLS CUI [1]
- C1705586
Description
Adverse event; Pharmaceutical Preparations; Relationships
Data type
text
Alias
- UMLS CUI [1,1]
- C0877248
- UMLS CUI [1,2]
- C0013227
- UMLS CUI [1,3]
- C0439849
Description
Adverse event; Disease; Relationships
Data type
text
Alias
- UMLS CUI [1,1]
- C0877248
- UMLS CUI [1,2]
- C0012634
- UMLS CUI [1,3]
- C0439849
Description
Investigator Signature
Alias
- UMLS CUI-1
- C2346576
Similar models
Concomitant Medications and Transfusions and Adverse Experiences
- StudyEvent: ODM
C1704732 (UMLS CUI [1,2])
C1517741 (UMLS CUI [1,2])
C0521115 (UMLS CUI-2)
C1879316 (UMLS CUI-3)
C0521115 (UMLS CUI-4)
C0456388 (UMLS CUI [2])
C0178602 (UMLS CUI [1,2])
C0456388 (UMLS CUI [2,1])
C0178602 (UMLS CUI [2,2])
C0178602 (UMLS CUI [1,2])
C0439148 (UMLS CUI [1,3])
C0456388 (UMLS CUI [2,1])
C0178602 (UMLS CUI [2,2])
C0439148 (UMLS CUI [2,3])
C1879316 (UMLS CUI [2,1])
C0439603 (UMLS CUI [2,2])
C0237753 (UMLS CUI [1,2])
C0806020 (UMLS CUI [1,2])
C0549178 (UMLS CUI [1,2])
C0439603 (UMLS CUI [1,2])
C0087111 (UMLS CUI [1,2])
C0079809 (UMLS CUI [1,3])
C0079809 (UMLS CUI [1,2])
C0205394 (UMLS CUI [1,3])
C0079809 (UMLS CUI [1,2])
C0205394 (UMLS CUI [1,3])
C2348235 (UMLS CUI [1,4])
C0013227 (UMLS CUI [1,2])
C0439849 (UMLS CUI [1,3])
C0012634 (UMLS CUI [1,2])
C0439849 (UMLS CUI [1,3])